Search research articles
Contact Us
Filters
Showing results (81-90 of 135) with videos related to
Page
of 14
Sort By:
Brachytherapy
|
October 9, 2018
Permanent prostate brachytherapy monotherapy with I-125 for low- and intermediate-risk prostate cancer: Outcomes in 974 patients
David M Routman, Ryan K Funk, Bradley J Stish, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 28, 2017
Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography
William P Parker, Jaden D Evans, Bradley J Stish, et al.
BJU International
|
July 21, 2015
Proposed prognostic scoring system evaluating risk factors for biochemical recurrence of prostate cancer after salvage radiation therapy
Richard J Lee, Katherine S Tzou, Michael G Heckman, et al.
The Journal of Urology
|
August 8, 2006
Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system
Steven J Buskirk, Thomas M Pisansky, Steven E Schild, et al.
Practical Radiation Oncology
|
June 28, 2016
Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases
Hania A Al-Hallaq, Steven Chmura, Joseph K Salama, et al.
Plos One
|
March 18, 2016
An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer
Michael G Heckman, Jessica L Robinson, Katherine S Tzou, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 6, 2021
Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526)
Juanita Crook, Joseph P Rodgers, Thomas M Pisansky, et al.
JAMA Oncology
|
February 15, 2019
Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial
Deborah W Bruner, Stephanie L Pugh, W Robert Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 24, 2014
Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910
Thomas M Pisansky, Daniel Hunt, Leonard G Gomella, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 22, 2019
Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902
Daniel A Hamstra, Stephanie L Pugh, Herbert Lepor, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 135) with videos related to
Sort By:
Page
of 14
Brachytherapy
|
October 9, 2018
Permanent prostate brachytherapy monotherapy with I-125 for low- and intermediate-risk prostate cancer: Outcomes in 974 patients
David M Routman, Ryan K Funk, Bradley J Stish, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 28, 2017
Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography
William P Parker, Jaden D Evans, Bradley J Stish, et al.
BJU International
|
July 21, 2015
Proposed prognostic scoring system evaluating risk factors for biochemical recurrence of prostate cancer after salvage radiation therapy
Richard J Lee, Katherine S Tzou, Michael G Heckman, et al.
The Journal of Urology
|
August 8, 2006
Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system
Steven J Buskirk, Thomas M Pisansky, Steven E Schild, et al.
Practical Radiation Oncology
|
June 28, 2016
Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases
Hania A Al-Hallaq, Steven Chmura, Joseph K Salama, et al.
Plos One
|
March 18, 2016
An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer
Michael G Heckman, Jessica L Robinson, Katherine S Tzou, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 6, 2021
Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526)
Juanita Crook, Joseph P Rodgers, Thomas M Pisansky, et al.
JAMA Oncology
|
February 15, 2019
Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial
Deborah W Bruner, Stephanie L Pugh, W Robert Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 24, 2014
Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910
Thomas M Pisansky, Daniel Hunt, Leonard G Gomella, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 22, 2019
Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902
Daniel A Hamstra, Stephanie L Pugh, Herbert Lepor, et al.
Page
of 14